{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T01:46:09Z","timestamp":1649123169820},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1988,4,1]],"date-time":"1988-04-01T00:00:00Z","timestamp":575856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1988,4]]},"DOI":"10.1007\/bf03350149","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T19:34:23Z","timestamp":1397158463000},"page":"261-265","source":"Crossref","is-referenced-by-count":3,"title":["Effects of naloxone on adrenal cortex regulation in patients with primary aldosteronism"],"prefix":"10.1007","volume":"11","author":[{"given":"F.","family":"Fallo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Boscaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Sonino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Mantero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"issue":"Suppl.1","key":"BF03350149_CR1","first-page":"1","volume":"34","author":"RE McCaa","year":"1974","unstructured":"McCaa R.E., Young D.B., Guyton A.C., McCaa C.S. Evidence for a role of an unidentified pituitary factor in regulating aldosterone secretion during altered sodium balance. Circ. Res. 34(Suppl. 1): 1\u201315, 1974.","journal-title":"Circ. Res."},{"key":"BF03350149_CR2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1126\/science.6247763","volume":"209","author":"H Matsuoka","year":"1980","unstructured":"Matsuoka H., Mulrow P.J. \u03b2-lipotropin: a new aldosterone-stimulating factor. Science 209: 307, 1980.","journal-title":"Science"},{"issue":"Suppl.1","key":"BF03350149_CR3","first-page":"181","volume":"3","author":"SR Sen","year":"1981","unstructured":"Sen S.R., Valenzuela R., Smeby R., Bravo E.L., Bumpus F.M. Localization, purification, and biological activity of a new aldosterone-stimulating factor. Hypertension 3(Suppl. 1): 181, 1981.","journal-title":"Hypertension"},{"key":"BF03350149_CR4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/291155a0","volume":"291","author":"H Matsuoka","year":"1981","unstructured":"Matsuoka H., Mulrow P.J., Franco-Saenz R., Li C.H. Stimulation of aldosterone production by \u03b2-melanotropin. Nature 291: 155, 1981.","journal-title":"Nature"},{"key":"BF03350149_CR5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2265.1981.tb00668.x","volume":"15","author":"T Smith","year":"1981","unstructured":"Smith T., Grossman A., Gaillard R., Clement-Jones V., Ratter S., Mallinson J., Lowry P.J., Besser M., Rees L. Studies on circulating met-enkephalin and beta-endorphin: normal subjects and patients with renal and adrenal disease. Clin. Endocrinol. (Oxf.) 15: 291, 1981.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03350149_CR6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-2007-1018663","volume":"15","author":"EL Schiffrin","year":"1983","unstructured":"Schiffrin E.L., Chretien M., Seidah N.G., Lis M., Gutkowska J., Cantin M., Genest J. Response of human aldosterenoma cells in culture to N-terminal-glycopeptide of pro-opiomelanocortin and \u03b3 3-MSH. Horm. Metab. Res. 15: 181, 1983.","journal-title":"Horm. Metab. Res."},{"key":"BF03350149_CR7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jcem-60-3-485","volume":"60","author":"AL Rabinowe","year":"1985","unstructured":"Rabinowe A.L., Taylor T., Dluhy R.G., Williams G. \u03b2-endorphin stimulates plasma renin and aldosterone release in normal human subjects. J. Clin. Endocrinol. Metab. 60: 485, 1985.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350149_CR8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1210\/jcem-60-2-315","volume":"60","author":"GT Griffing","year":"1985","unstructured":"Griffing G.T., Mclntosh T., Berelowitz B., Hudson M., Salzman R., Manson J.A.E., Melby J.C. Plasma \u03b2-endorphin levels in primary aldosteronism. J. Clin. Endocrinol. Metab. 60: 315, 1985.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350149_CR9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1172\/JCI111941","volume":"76","author":"GT Griffing","year":"1985","unstructured":"Griffing G.T., Berelowitz B., Hudson M., Salzman R., Manson J.A.E., Aurrechia S., Melby J.C., Pedersen R.C., Brownie A.C. Plasma immunoreactive gamma melanotropin in parents with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension. J. Clin. Invest. 76: 163, 1985.","journal-title":"J. Clin. Invest."},{"key":"BF03350149_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/edrv-1-1-1","volume":"1","author":"BA Eipper","year":"1980","unstructured":"Eipper B.A., Mains R.E. Structure and biosynthesis of proadrenocorticotropin\/ endorphin and related peptides. Endocr. Rev. 1: 1, 1980.","journal-title":"Endocr. Rev."},{"key":"BF03350149_CR11","first-page":"234","volume":"25","author":"PJ Lowry","year":"1987","unstructured":"Lowry P.J. The \u201ctwo-site\u201d immunoradiometric assay. In \u201cEndorphins: assay and physiological significance\u201d, Workshop organized by the European Programme of Research on Breakdown in Adaptation, Li\u00e8ge, May 30\u201331, 986 (Abstract). Horm. Res. 25: 234, 1987.","journal-title":"Horm. Res."},{"issue":"Suppl.2","key":"BF03350149_CR12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.RES.28.5_Suppl_2.II-175","volume":"28","author":"JR Stockigt","year":"1971","unstructured":"Stockigt J.R., Collins R.D., Biglieri E.G. Determination of plasma renin concentration by angiotensin I immunoassay: diagnostic importance of a precise measurement of subnormal renin in hyperaldosteronism. Circ. Res. 28(Suppl. 2): 175, 1971.","journal-title":"Circ. Res."},{"key":"BF03350149_CR13","first-page":"1056","volume":"300","author":"J Volavka","year":"1979","unstructured":"Volavka J., Cho D., Mallya A., Bauman J. Naloxone increases ACTH and cortisol levels in normal man. N.Engl. J. Med. 300: 1056, 1979.","journal-title":"N.Engl. J. Med."},{"key":"BF03350149_CR14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/jcem-50-2-251","volume":"50","author":"JE Morley","year":"1980","unstructured":"Morley J.E., Baranetsky N.G.,Wingert T.D., Carlson H.E., Hersham J.H., Melmed S., Levin S.R., Jalison K.R., Weizman R., Chang R.J., Varner A.A. Endocrine effects of naloxone-induced opiate receptor blockade. J. Clin. Endocrinol. Metab. 50: 251, 1980.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350149_CR15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000124463","volume":"42","author":"A Grossman","year":"1986","unstructured":"Grossman A., Moult P.J., Cunnah D., Besser M. Different opioid mechanisms are involved in the modulation of ACTH and gonadotropin release in man. Neuroendocrinology 42: 357, 1986.","journal-title":"Neuroendocrinology"},{"key":"BF03350149_CR16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2265.1981.tb00636.x","volume":"14","author":"RC Gaillard","year":"1981","unstructured":"Gaillard R.C., Grossman A., Smith R., Rees LH., Besser G.M. The effect of met-enkephalin analog on ACTH, \u03b2-endorphin and met-enkephalin in patients with adrenocortical disease. Clin. Endocrinol. (Oxf.) 14: 471, 1981.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03350149_CR17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-2007-1013458","volume":"17","author":"RDG Leslie","year":"1985","unstructured":"Leslie R.D.G., Prescott R.W.G., Kendall-Taylor P., Cook D., Weightman D., Ratcliffe J.O., Ingram M.C. Opiate receptor blockade and diurnal pituitary and adrenal hormone levels. Horm. Metab. Res. 17: 86, 1985.","journal-title":"Horm. Metab. Res."},{"key":"BF03350149_CR18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2265.1987.tb00772.x","volume":"26","author":"F Fallo","year":"1986","unstructured":"Fallo F., Boscaro M., Sonino N., Mantero F. Effects of naloxone on the pituitary-adrenal axis in patients with dexamethasone-suppressible hyperaldo-steronism. Clin. Endocrinol. (Oxf.) 26: 163, 1986.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03350149_CR19","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0006-291X(80)80015-5","volume":"97","author":"K Racz","year":"1980","unstructured":"Racz K., Glaz E., Kiss R., Lada G., Varga I., Vida I., Di Gleria K., Medzihradszky K., Lichtwald K., Vecsei P. Adrenal cortex-a newly recognized peripheral site of actions of enkephalins. Biochem. Biophys. Res. Commun. 97: 1346, 1980.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF03350149_CR20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1210\/endo-109-4-1132","volume":"109","author":"JH Lymangrover","year":"1981","unstructured":"Lymangrover J.H., Dokas L.A., Kong A., Martin R., Saffran M. Naloxone has a direct effect on the adrenal cortex. Endocrinology 109: 1132, 1981.","journal-title":"Endocrinology"},{"key":"BF03350149_CR21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1210\/jcem-48-5-861","volume":"48","author":"E Saito","year":"1979","unstructured":"Saito E., Ichigawa Y., Homma M. Direct inhibitory effect of dexamethasone on human adrenal \u201cin vivo\u201d. J. Clin. Endocrinol. Metab. 48: 861, 1979.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350149_CR22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1210\/jcem-56-4-853","volume":"59","author":"HG G\u00fcllner","year":"1983","unstructured":"G\u00fcllner H.G., Nicholson W.E., Gill J.E., Orth D.N. Plasma immunoreactive proopiomelanocortin-derived peptides in patients with primary aldosteronism, idiopathic hyperaldosteronism with bilateral adrenal hyperplasia, and dexamethasone-suppressible hyperaldosteronism. J. Clin. Endocrinol. Metab. 59: 853, 1983.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03350149_CR23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1042\/cs0680185","volume":"68","author":"M Bramnert","year":"1985","unstructured":"Bramnert M., Hokfelt B. Lack of effect of naloxone in a moderate dosage on the exercise-induced increase in blood pressure, heart rate, plasma catecholamines, plasma renin activity and plasma aldosterone in healthy males. Clin. Sci. 68: 185, 1985.","journal-title":"Clin. Sci."},{"key":"BF03350149_CR24","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/0024-3205(83)90702-6","volume":"33","author":"JH Lymangrover","year":"1983","unstructured":"Lymangrover J.H., Keku E., Eldridge J.C. Naloxone potentiates ACTH and angiotensin but not potassium stimulated aldosterone secretion. Life Sci. 33: 1605, 1983.","journal-title":"Life Sci."},{"key":"BF03350149_CR25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.6250217","volume":"209","author":"ND Kalin","year":"1980","unstructured":"Kalin N.D., Risch S.C., Cohen R.M., Insel T., Murphy D.L. Dexamethasone fails to suppress \u03b2-endorphin plasma concentrations in humans and rhesus monkeys. Science 209: 827, 1980.","journal-title":"Science"},{"key":"BF03350149_CR26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1056\/NEJM198107233050401","volume":"305","author":"MD Gross","year":"1981","unstructured":"Gross M.D., Grekin R.J., Gniadek T.C., Villareal J.Z. Suppression of aldosterone by cyproheptadine in idiopathic hyperaldosteronism. N.Engl. J. Med. 305: 181, 1981.","journal-title":"N.Engl. J. Med."},{"key":"BF03350149_CR27","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.6308766","volume":"221","author":"JE Evans","year":"1983","unstructured":"Evans J.E., Erdelyi E., Weber E., Barchas J.D. Identification of pro-opiomelanocortin derived peptides in the human adrenal medulla. Science 221: 957, 1983.","journal-title":"Science"},{"key":"BF03350149_CR28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF03350587","volume":"6","author":"H Imura","year":"1983","unstructured":"Imura H., Nakai Y., Nakao K., Oki S., Tanaka I., Jingami H., Yoshimasa T., Tsukada T., Ikeda Y., Suda M., Sakamoto M. Biosynthesis and distribution of opioid peptides. J. Endocrinol. Invest. 6: 139, 1983.","journal-title":"J. Endocrinol. Invest."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03350149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03350149\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03350149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T10:46:59Z","timestamp":1558522019000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03350149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1988,4]]}},"alternative-id":["BF03350149"],"URL":"https:\/\/doi.org\/10.1007\/bf03350149","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,4]]}}}